Yayın:
Detailed polymorphism study on cytomegalovirus DNA polymerase gene to reveal the most suitable genomic targets for quantitative Real-time PCR

dc.contributor.authorBilenoglu, Onur
dc.contributor.authorAltindis, Mustafa
dc.contributor.authorOz, Ersoy
dc.contributor.authorYucel-Oz, Yeliz
dc.contributor.authorIrigul-Sonmez, Oyku
dc.contributor.authorUnal, Can Bora
dc.contributor.institutionauthorÖZ, Ersoy
dc.date.accessioned2026-06-27T13:43:22Z
dc.date.issued2015
dc.description.abstractThe human cytomegalovirus (HCMV) is an important human pathogen primarily affecting immunocompromised patients, like transplant recipients or HIV-infected individuals. Early diagnosis of cytomegalovirus (CMV) infection in high-risk patients is essential in order to start preemptive treatments. pol (UL54) gene encoding for HCMV viral DNA polymerase is a well-defined target for HCMV detection in clinical samples and identifying most highly conserved regions for primer design remains crucial. Though real-time polymerase chain reaction (qPCR) is a rapid and sensitive method for HCMV detection, failure to detect some HCMV strains due to primer and target mismatches have led the researchers to explore more sensitive and reliable methods. Hence, to understand the broader diversity of the pol mutations in HCMV and to specify the most suitable region for primer-probe design to be used in qPCR assay, we studied both nucleotide and amino acid heterogeneities in 60 HCMV positive samples that were collected to represent national mutational prevalence of pol gene of HCMV in Turkey. The test was designed with a new set of primers-probe for HCMV detection and quantification based on the sequencing data which revealed the most conserved region on the pol gene. Statistical probit analysis was applied on qPCR studies which revealed a 95% detection limit of 100 copies/mL. In addition, linearity, reproducibility, and precision of the new test were assessed for diagnostic purposes.en
dc.description.urihttps://doi.org/10.17305/bjbms.2015.494
dc.identifier.doi10.17305/bjbms.2015.494
dc.identifier.eissn1840-4812
dc.identifier.endpage34
dc.identifier.issn1512-8601
dc.identifier.issue3
dc.identifier.pubmed26295291
dc.identifier.startpage28
dc.identifier.urihttps://hdl.handle.net/20.500.14981/54482
dc.identifier.volume15
dc.identifier.wos000361745100004
dc.language.isoeng
dc.publisherASSOC BASIC MEDICAL SCI FEDERATION BOSNIA & HERZEGOVINA SARAJEVO
dc.relation.ispartofBOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES
dc.rightsopenAccess
dc.subjectCytomegalovirus
dc.subjectnucleotide variations
dc.subjectreal-time polymerase chain reaction
dc.subjectpol gene
dc.subjectTRANSPLANT RECIPIENTS
dc.subjectIMMUNOCOMPROMISED PATIENTS
dc.subjectANTIVIRAL DRUGS
dc.subjectRESISTANCE
dc.subjectGANCICLOVIR
dc.subjectRETINITIS
dc.subjectSTRAINS
dc.subjectFOSCARNET
dc.subjectTHERAPY
dc.subjectResearch & Experimental Medicine
dc.titleDetailed polymorphism study on cytomegalovirus DNA polymerase gene to reveal the most suitable genomic targets for quantitative Real-time PCR
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar